Tadeusz Pieńkowski
Impact in
- Oncology top 0.1%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
- Cancer Research top 0.2%
- Breast Cancer Treatment Studies
Papers in
- Oncology 108
- HER2/EGFR in Cancer Research 63
- Cancer Treatment and Pharmacology 61
- Peptidase Inhibition and Analysis 10
- Colorectal Cancer Treatments and Studies 8
-
- Breast Cancer Treatment Studies 42
- Co-authors
- Young‐Hyuck ImJosé Luiz PedriniGraham RossSeock‐Ah ImLaslo RomanJohn CrownSemiglazov VfJosé Baselga
- Journals
- Journal of Clinical Oncology (38 papers)Cancer Research (9 papers)Annals of Oncology (8 papers)The Lancet Oncology (5 papers)European Journal of Cancer (3 papers)
- Partner nations
- PolandUnited StatesSpain
In The Last Decade
Tadeusz Pieńkowski
124 papers receiving 11.7k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Oncology 9.6k
- Cancer Research 3.8k
- Radiology, Nuclear Medicine and Imaging 3.3k
- Pulmonary and Respiratory Medicine 2.5k
- Genetics 765
Countries citing papers authored by Tadeusz Pieńkowski
This map shows the geographic impact of Tadeusz Pieńkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadeusz Pieńkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadeusz Pieńkowski more than expected).
Fields of papers citing papers by Tadeusz Pieńkowski
This network shows the impact of papers produced by Tadeusz Pieńkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadeusz Pieńkowski. The network helps show where Tadeusz Pieńkowski may publish in the future.
Co-authors
The 25 scholars most cited alongside Tadeusz Pieńkowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 22 | |
| 2 | 2018 | 25 | |
| 3 | The role of anthracyclines and dose dense therapy in an adjuvant setting, in HER2-positive early breast cancer, in clinical practice | 2016 | 1 |
| 4 | 2015 | 57 | |
| 5 | 2014 | 24 | |
| 6 | 2013 | 19 | |
| 7 | 2010 | 11 | |
| 8 | 2009 | 43 | |
| 9 | 2009 | 133 | |
| 10 | Bisfosfoniany w zapobieganiu i kontroli zdarzeń kostnych u chorych z przerzutami nowotworów złośliwych do kości | 2006 | 0 |
| 11 | 2006 | 166 | |
| 12 | 2004 | 202 | |
| 13 | Rak piersi - rozpoznawanie, leczenie, profilaktyka | 2004 | 0 |
| 14 | Diagnosis and treatment of breast cancer | 2003 | 3 |
| 15 | "Cancer of the breast" (Donegan & Spratt) | 2002 | 1 |
| 16 | Changes in BRCA1 gene in patients with familial breast cancer in the Warsawregion of Poland | 2002 | 2 |
| 17 | Dose intensity of adjuvant CMF chemotherapy program for breast cancer | 2001 | 1 |
| 18 | Expression of HER2/neu in primary and metastatic breast cancer. | 2001 | 4 |
| 19 | Predictive factors in breast cancer patients | 2000 | 2 |
| 20 | 1997 | 80 |
About Tadeusz Pieńkowski
Tadeusz Pieńkowski is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 129 papers that have together received 12.0k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (63 papers), Cancer Treatment and Pharmacology (61 papers), Breast Cancer Treatment Studies (42 papers), Advanced Breast Cancer Therapies (24 papers), Monoclonal and Polyclonal Antibodies Research (15 papers), Peptidase Inhibition and Analysis (10 papers), Estrogen and related hormone effects (9 papers) and Colorectal Cancer Treatments and Studies (8 papers). The work is most often cited by research in Oncology (9.6k citations), Cancer Research (3.8k citations), Radiology, Nuclear Medicine and Imaging (3.3k citations), Pulmonary and Respiratory Medicine (2.5k citations) and Genetics (765 citations). Tadeusz Pieńkowski has collaborated with scholars based in Poland, United States and Spain. Frequent co-authors include Young‐Hyuck Im, José Luiz Pedrini, Graham Ross, Seock‐Ah Im, Laslo Roman, John Crown, Semiglazov Vf, José Baselga, Agnieszka Jagiełło-Gruszfeld and Stephen Chan. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, The Lancet Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.